Abstract
Interleukin (IL)-4 and IL-13 control the phenotype of a variety of cells in health and disease. Their receptor system, signaling cascades, and functional properties have gained clarity in the past 30. years. In this article, we give an overview of the production, sensing, and effects of both cytokines concluding with a discussion of the therapeutic potential of IL-4 and IL-13 inhibition or supplementation in patients.
| Original language | English |
|---|---|
| Title of host publication | Molecular Immunology |
| Publisher | Elsevier Inc. |
| Pages | 519-524 |
| Number of pages | 6 |
| Volume | 2 |
| ISBN (Print) | 9780080921525 |
| DOIs | |
| State | Published - 27 04 2016 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2016 Elsevier Ltd All rights reserved.
Keywords
- Allergy
- Alternative activation
- Biologics
- Fibrosis
- IL-13
- IL-4
- Mast cells
- Signaling
- Th2 cells